Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib

Title
Next-generation sequencing based mutation profiling reveals heterogeneity of clinical response and resistance to osimertinib
Authors
Keywords
-
Journal
LUNG CANCER
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2019-11-25
DOI
10.1016/j.lungcan.2019.10.021

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now